Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Economic News/Analysis

Forrester: Generative AI Dominates Top 10 Emerging Technologies In 2023 And Beyond


According to Forrester's (Nasdaq: FORR) The Top 10 Emerging Technologies In 2023 report, generative AI will begin to deliver significant return on investment for most enterprises in the next two to four years. To fully benefit from generative AI's applications, firms will need to navigate its risks, including trustworthiness, evolving regulations, and potential intellectual property complications. Despite these risks, generative AI remains a top emerging technology to invest in due to its breadth of impact and ability to accelerate many other top emerging technologies, including autonomous workplace assistants (AWAs) and conversational AI.

Conversational AI, enabled by generative AI, is the second top emerging technology that will deliver the fastest ROI. E-commerce, B2B sales, and customer service functions will see the biggest impacts from conversational AI. AWAs will also deliver near-term benefits for most firms, as they are poised today to take over increasingly complex but repetitive human tasks.

According to Forrester, additional emerging technologies that will offer significant benefits for firms in two to four years include:

Some emerging technologies that will take at least five years to deliver tangible value for enterprises include:

"While many emerging technologies show great promise, it is imperative for tech leaders to assess whether these technologies can deliver value and if their business can navigate their associated risks," said Brian Hopkins, Forrester VP, emerging technology portfolio. "This means side-stepping misinformation, mitigating poor decisions driven by a fear of missing out, and narrowing focus from the shiny objects down to the few technologies that have real potential. Firms must also ensure that their time frame for implementing these technologies is commensurate with their overall risk/reward tolerance."

Resources:

About Forrester

Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester's proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work ? to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wavetm evaluations; 100 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com.


These press releases may also interest you

at 06:02
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...

at 06:00
Amplify10, the trailblazer in SaaS AI-Powered Sales Execution solutions, proudly announces its official launch today, aimed at reshaping the landscape of sales performance for enterprises worldwide. The early-stage company, formerly known as...

at 06:00
Quhuo Limited ("Quhuo" or the "Company") , a leading gig economy platform focusing on local life services in China, today announced that Ms. Chenxi Zhao has resigned from her position as a member of the board of directors (the "Board"), effective on...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:45
A report from China.org.cn:  China Duty Free Group (CDFG), the world's leading travel retail operator, outlined its strategy for continued growth at the recently concluded TFWA Asia Pacific Exhibition & Conference held in Singapore from May 12 to...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...



News published on and distributed by: